Clinical Features and Predictors of Dysplasia in Proximal Sessile Serrated Lesions
1
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Background/Aims: Proximal colorectal cancers (CRCs) account for up to half of CRCs. Sessile serrated lesions (SSLs) are precursorsto CRC. Proximal location and presence of dysplasia in SSLs predict higher risks of progression to cancer. The prevalence of dysplasiain proximal SSLs (pSSLs) and clinical characteristics of dysplastic pSSLs are not well studied. Methods: Endoscopically resected colonic polyps at our center between January 2016 and December 2017 were screened for pSSLs. Data of patients with at least one pSSL were retrieved and clinicopathological features of pSSLs were analysed. pSSLs with andwithout dysplasia were compared for associations. Results: Ninety pSSLs were identified, 45 of which had dysplasia giving a prevalence of 50.0%. Older age (65.9 years vs. 60.1 years,p=0.034) was associated with the presence of dysplasia. Twelve pSSLs were 10 mm or larger. After adjusting for age, pSSLs ≥10 mmhad an adjusted odds ratio of 5.98 (95% confidence interval, 1.21–29.6) of having dysplasia compared with smaller pSSLs. Conclusions: In our cohort of pSSLs, the prevalence of dysplasia is high at 50.0% and is associated with lesion size ≥10 mm. Endoscopic resection for all proximal serrated lesions should be en-bloc to facilitate accurate histopathological examination fordysplasia as its presence warrants shorter surveillance intervals.
Abstract
Background/Aims: Proximal colorectal cancers (CRCs) account for up to half of CRCs. Sessile serrated lesions (SSLs) are precursorsto CRC. Proximal location and presence of dysplasia in SSLs predict higher risks of progression to cancer. The prevalence of dysplasiain proximal SSLs (pSSLs) and clinical characteristics of dysplastic pSSLs are not well studied. Methods: Endoscopically resected colonic polyps at our center between January 2016 and December 2017 were screened for pSSLs. Data of patients with at least one pSSL were retrieved and clinicopathological features of pSSLs were analysed. pSSLs with andwithout dysplasia were compared for associations. Results: Ninety pSSLs were identified, 45 of which had dysplasia giving a prevalence of 50.0%. Older age (65.9 years vs. 60.1 years,p=0.034) was associated with the presence of dysplasia. Twelve pSSLs were 10 mm or larger. After adjusting for age, pSSLs ≥10 mmhad an adjusted odds ratio of 5.98 (95% confidence interval, 1.21–29.6) of having dysplasia compared with smaller pSSLs. Conclusions: In our cohort of pSSLs, the prevalence of dysplasia is high at 50.0% and is associated with lesion size ≥10 mm. Endoscopic resection for all proximal serrated lesions should be en-bloc to facilitate accurate histopathological examination fordysplasia as its presence warrants shorter surveillance intervals.
참고문헌 (51)
- Muto T, "The evolution of cancer of the colon and rectum", Cancer, 36, pp.2251~2270 (1975)
- Boparai KS, "A serrated colorectal cancer pathway predominates over the classic WNT pathway in patients with hyperplastic polyposis syndrome", Am J Pathol, 178, pp.2700~2707 (2011)
- Leggett B, "Role of the serrated pathway in colorectal cancer pathogenesis", Gastroenterology, 138, pp.2088~2100 (2010)
- Jass JR, "Classification of colorectal cancer based on correlation of clinical, morphological and molecular features", Histopathology, 50, pp.113~130 (2007)
- Bettington M, "The serrated pathway to colorectal carcinoma : current concepts and challenges", Histopathology, 62, pp.367~386 (2013)
- Gomez D, "Anatomical distribution of colorectal cancer over a 10 year period in a district general hospital : is there a true"rightward shift"?", Postgrad Med J, 80, pp.667~669 (2004)
- Baber J, "Anatomical distribution of colorectal cancer in a Veterans Affairs Medical Center", South Med J, 107, pp.443~447 (2014)
- Siegel RL, "Cancer statistics, 2020", CA Cancer J Clin, 70, pp.7~30 (2020)
- Dekker E, "Colorectal cancer", Lancet, 394, pp.1467~1480 (2019)
- Missiaglia E, "Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features", Ann Oncol, 25, pp.1995~2001 (2014)
- Keum N, "Global burden of colorectal cancer : emerging trends, risk factors and prevention strategies", Nat Rev Gastroenterol Hepatol, 16, pp.713~732 (2019)
- Joseph C. Anderson, "Pathogenesis and Management of Serrated Polyps: Current Status and Future Directions", Gut and Liver, 8(6), pp.582~589 (2014), 거트앤리버 소화기연관학회협의회
- Kahi CJ, "Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy", Clin Gastroenterol Hepatol, 9, pp.42~46 (2011)
- JE IJ, "Prevalence, distribution and risk of sessile serrated adenomas", polyps at a center with a high adenoma detection rate and experienced pathologists, 2016, pp.48, 740~746
- Erichsen R, "Increased risk of colorectal cancer development among patients with serrated polyps", Gastroenterology, 150, pp.895~902 (2016)
- Bettington M, "Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma", Gut, 66, pp.97~106 (2017)
- Holme Ø, "Long-term risk of colorectal cancer in individuals with serrated polyps", Gut, 64, pp.929~936 (2015)
- IJspeert JEG, "Detection rate of serrated polyps and serrated polyposis syndrome in colorectal cancer screening cohorts : a European overview", Gut, 66, pp.1225~1232 (2017)
- Snover DC, "Update on the serrated pathway to colorectal carcinoma", Hum Pathol, 42, pp.1~10 (2011)
- Burgess NG, "Sessile serrated adenomas", polyps with cytologic dysplasia : a triple threat for interval cancer, 2014, pp.80, 307~310
- Liu C, "Sessile serrated adenomas with dysplasia : morphological patterns and correlations with MLH1 immunohistochemistry", Mod Pathol, 30, pp.1728~1738 (2017)
- Yang JF, "Anatomic distribution of sessile serrated adenoma", polyp with and without cytologic dysplasia, 2015, pp.139, 388~393
- Abdeljawad K, "Sessile serrated polyp prevalence determined by a colonoscopist with a high lesion detection rate and an experienced pathologist", Gastrointest Endosc, 81, pp.517~524 (2015)
- Bouwens MW, "Endoscopic characterization of sessile serrated adenomas", polyps with and without dysplasia, 2014, pp.46, 225~235
- Hazewinkel Y, "Prevalence of serrated polyps and association with synchronous advanced neoplasia in screening colonoscopy", Endoscopy, 46, pp.219~224 (2014)
- Lash RH, "Sessile serrated adenomas : prevalence of dysplasia and carcinoma in 2139 patients", J Clin Pathol, 63, pp.681~686 (2010)
- Sheridan TB, "Sessile serrated adenomas with low-and high-grade dysplasia and early carcinomas : an immunohistochemical study of serrated lesions"caught in the act"", Am J Clin Pathol, 126, pp.564~571 (2006)
- Armaghany T, "Genetic alterations in colorectal cancer", Gastrointest Cancer Res, 5, pp.19~27 (2012)
- Pan J, "Colonoscopy reduces colorectal cancer incidence and mortality in patients with non-malignant findings : a meta-analysis", Am J Gastroenterol, 111, pp.355~365 (2016)
- Nishihara R, "Long-term colorectal-cancer incidence and mortality after lower endoscopy", N Engl J Med, 369, pp.1095~1105 (2013)
- JE IJ, "Serrated neoplasia-role in colorectal carcinogenesis and clinical implications", Nat Rev Gastroenterol Hepatol, 12, pp.401~409 (2015)
- Anderson JC, "Providing data for serrated polyp detection rate benchmarks : an analysis of the New Hampshire Colonoscopy Registry", Gastrointest Endosc, 85, pp.1188~1194 (2017)
- Sarvepalli S, "Association of adenoma and proximal sessile serrated polyp detection rates with endoscopist characteristics", JAMA Surg, 154, pp.627~635 (2019)
- Murakami T, "Distinct endoscopic characteristics of sessile serrated adenoma", polyp with and without dysplasia, Gastrointest Endosc, pp.2017, 85[DOI]
- Sano W, "Clinical and endoscopic evaluations of sessile serrated adenoma", polyps with cytological dysplasia, 2018, pp.33, 1454~1460
- Rustagi T, "Sessile serrated adenomas in the proximal colon are likely to be flat, large and occur in smokers", World J Gastroenterol, 19, pp.5271~5277 (2013)
- WHO classification of tumours, "Chapter: Colorectal serrated lesions and polyps", pp.165~167 (2019), International Agency for Research on Cancer
- Bufill JA, "Colorectal cancer : evidence for distinct genetic categories based on proximal or distal tumor location", Ann Intern Med, 113, pp.779~788 (1990)
- Rutter MD, "British Society of Gastroenterology", Association of Coloproctology of Great Britain and Ireland, Gut, pp.2020, 69[DOI]
- Gupta S, "Recommendations for follow-up after colonoscopy and polypectomy : a consensus update by the US Multi-Society Task Force on Colorectal Cancer", Gastrointest Endosc, 91, pp.463~485 (2020)
- Kim KH, "Clinical and endoscopic characteristics of sessile serrated adenomas", polyps with dysplasia, Sci Rep, pp.2019, 9[DOI]
- Burgess NG, "Clinical and endoscopic predictors of cytological dysplasia or cancer in a prospective multicentre study of large sessile serrated adenomas", polyps, 2016, pp.65, 437~446
- Yan HHN, "RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation", Gut, 66, pp.1645~1656 (2017)
- Nguyen LH, "Pathways of colorectal carcinogenesis", Gastroenterology, 158, pp.291~302 (2020)
- He X, "Long-term risk of colorectal cancer after removal of conventional adenomas and serrated polyps", Gastroenterology, 158, pp.852~861 (2020)
- Kaltenbach T, "Endoscopic removal of colorectal lesions-recommendations by the US Multi-Society Task Force on Colorectal Cancer", Gastroenterology, 158, pp.1095~1129 (2020)
- Davenport JR, "Modifiable lifestyle factors associated with risk of sessile serrated polyps, conventional adenomas and hyperplastic polyps", Gut, 67, pp.456~465 (2018)
- Ng SC, "Association between serrated polyps and the risk of synchronous advanced colorectal neoplasia in average-risk individuals", Aliment Pharmacol Ther, 41, pp.108~115 (2015)
- Liang PS, "Cigarette smoking and colorectal cancer incidence and mortality : systematic review and meta-analysis", Int J Cancer, 124, pp.2406~2415 (2009)
- Carr PR, "Lifestyle factors and risk of sporadic colorectal cancer by microsatellite instability status : a systematic review and meta-analyses", Ann Oncol, 29, pp.825~834 (2018)
- Limsui D, "Cigarette smoking and colorectal cancer risk by molecularly defined subtypes", J Natl Cancer Inst, 102, pp.1012~1022 (2010)
